By default, COFEPRIS orders withdrawal of the drug for hypertension

Pachuca, Hidalgo.- The Federal Commission for Protection against Health Risks (COFEPRIS) has issued a national alert to remove from all pharmacies any drug to control blood pressure and heart problems with the active ingredient of the drug. Chinese origin "Valsartan". Measure that has been activated since last week in Hidalgo, according to the consultation yesterday of two companies present in the Republic of Mexico.
"As a precaution, COFEPRIS ordered the immobilization and non-commercialization of raw materials and all drugs containing Valsartan from the manufacturer Zhejiang Huahai Pharmaceutical CO., LTD, due to a quality defect" , is the argument of the official statement.
The federal agency conducts the investigation because of the international notification made by the company in China, on the detection of an impurity generated by the method of synthesis of the product Valsartan
This active ingredient is present in drugs used for the treatment of heart failure and as antihypertensive.
They added the list of names because there are commercially known drugs with this ingredient: Diovalte, Vapispre, Vigilan, Avalraam, Menfhipress, Versalver and Vagsar
He included Vzar and Vigilan, but in a later bulletin, he informed that it has been proved that the active ingredient is not of Chinese origin, so he corrected.
Like any customer of the Farmacia del Ahorro and Guadalajara in downtown Pachuca and order one of these drugs, the employees agreed to inform sea that since last week "the authorities" has told them ordered to withdraw from sale those products that contain a Chinese active ingredient.
As stated in his statement COFEPRIS, was the same recommendation given by officials of both pharmacies, that if one consumes this drug go to his doctor to give him a substitute or alternative product, "but n & # Do not stop taking the medicine. "
The measure disseminated nationally obeys another international issued and that by cooperation protocols with COFEPRIS, acted accordingly, although the amount distributed at the national level of the enlisted is not known, let alone its equivalent in money.
Doctors also received the alert and were instructed to substitute the same composition and therapeutic indication that does not contain that of Chinese origin.
As part of the Health Secretariat of Hidalgo, through COPRISEH they carry out the dissemination This information will be sent to all medical units or health centers, so that, in the case where the patients who use said medicine are replaced, they will be replaced.
And if they have such a product in their pharmacy inventories, they will remove it. The staff of COFEPRIS who will pick it up, informed the official sources.